Sage Journals: Discover world-class research

Open access

Research article

First published 2024

The impact of pathogenic BRCA1/2 tumor mutation status on high grade serous epithelial ovarian cancer survival outcome: A multicenter study from Indonesia

Sutrisno Sutrisno, Dina Marlina, Kevin Dominique Tjandraprawira [...]

Sage Open Medicine

Open access

Review article

First published 2014

Hereditary Breast Cancer: Clinical,Pathological and Molecular Characteristics

Martin J. Larsen, Mads Thomassen, Anne-Marie Gerdes [...]

Breast Cancer: Basic and Clinical Research

Open access

Research article

First published 2025

Clinical and Pathological Characteristics and Treatment Implications of BRCA1 - and BRCA2 -Mutated Breast Cancer in Japanese Patients: A Single-Institution Retrospective Study

Yumiko Akita, Madoka Iwase, Toyone Kikumori [...]

Breast Cancer: Basic and Clinical Research

Retricted access

Research article

First published 2026

Prediction of Specific Survival and Clinicopathological Impact of Somatic PALB2 Mutations and Pathogenic/Likely Pathogenic Variants (PV/LPV) in Breast Cancer: A Cohort Study of 81 Patients

Yousef M. Hawsawi, Ibrahim Mansoor, Mutlay Sayan [...]

International Journal of Surgical Pathology

Retricted access

Case report

First published 2020-12

HPV nonrelated endocervical adenocarcinoma in hereditary cancer syndromes

Ileana Carnevali, Eleonora Di Lauro, Valeria Pensotti [...]

Tumori Journal

Open access

Research article

First published 2020

BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients

Lorena Incorvaia, Daniele Fanale, Marco Bono [...]

Therapeutic Advances in Medical Oncology

Open access

Case report

First published 2020

Olaparib is effective for recurrent urothelial carcinoma with BRCA2 pathogenic germline mutation: first report on olaparib response in recurrent UC

Hong Yang, Zhimin Liu, Yufang Wang [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2026

Emerging precision therapeutics for pancreatic ductal adenocarcinoma: KRAS and beyond

Ani Misirian, Jonathan Pai, Diana L. Hanna

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2026

Prevalence and impact of germline mutations in pancreatic ductal adenocarcinoma

Emir Gokhan Kahraman, Halil Taskaynatan, Taha Reşid Özdemir [...]

Tumori Journal

Search results